Two aspects of the COPE guidelines can be frustrating. First, the process can be quite slow. After an initial point regarding a paper is made, unless the authors choose to reply promptly, either to the commenters and/or us directly or publicly on social media, the time to closure can be long. If there is an ethics investigation, it most likely will be undertaken by the authors' institutions, and only results that change the publication status (i.e., additions/corrections or retractions) become known. Even then, the time delay can be months or even years from the original comments. As editors, we are able to label manuscripts with statements of concern during this period, but as a journal, editor, or publisher, we are not empowered as an investigative body and have essentially no investigative capabilities at our disposal other than our own and our advisors' expertise. In obvious cases, we can and do act unilaterally.
One fear is that the ethics oversight structure at a university, company, or research institution may be insufficient or could be motivated to act in self-protection. In the decade in which we have operated, we have only encountered this situation one time.
Luckily, we had enough information and expertise to handle this case. Nonetheless, this weak point remains, and we welcome your suggestions on how we as a community might address it.
Announcements. With the rising number and quality of our submissions, we are increasingly raising the thresholds for publication (and external review) at ACS Nano. I continue to read and to rate all submitted manuscripts within hours of submission, unless I have a conflict of interest with a specific one (in which case one of our associate editors takes over that manuscript for me). Then, I either send it to external referees or, more commonly, assign one of our associate editors with expertise in the field of the work to consider the manuscript further as well as to consult with other editors and external referees, as appropriate. In order to broaden our coverage and knowledge base and to maintain our speed and efficiency, we are now expanding our editorial ranks.
Prof. Omid Farokhzad of Harvard Medical School and
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